title: Bevacizumab and cancer treatment-related mortality.
authors.forename: Patricia B
authors.initials: PB
authors.lastname: Cerrito
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003627:Data Interpretation, Statistical; D006801:Humans; D016014:Linear Models; D009026:Mortality; D009369:Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab